We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet) (CaBaMet)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02166658
Recruitment Status : Terminated (After a recruitment of more than 2 years, only 8 patients have been registered.)
First Posted : June 18, 2014
Last Update Posted : January 23, 2018
ClinAssess GmbH
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 2017
  Study Completion Date : January 18, 2018